7WBP
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein in complex with its receptor human ACE2
Entity
Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
1 | A (A) | Angiotensin-converting enzyme 2 | polymer | 596 | 69038.6 | 1 | UniProt (Q9BYF1) Pfam (PF01401) | Homo sapiens (human) | ACE-related carboxypeptidase,Angiotensin-converting enzyme homolog |
2 | B (B) | Spike protein S1 | polymer | 223 | 25415.9 | 1 | UniProt (P0DTC2) Pfam (PF09408) | Severe acute respiratory syndrome coronavirus 2 | |
3 | C (C) | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | branched | 424.4 | 1 | In PDB GlyTouCan (G42666HT) | |||
4 | D, E, F, H, I (A, B) | 2-acetamido-2-deoxy-beta-D-glucopyranose | non-polymer | 221.2 | 5 | Chemie (NAG) | |||
5 | G (A) | ZINC ION | non-polymer | 65.4 | 1 | Chemie (ZN) |
Sequence modifications
B: 319 - 541 (UniProt: P0DTC2)
PDB | External Database | Details |
---|---|---|
Asp 339 | Gly 339 | engineered mutation |
Leu 371 | Ser 371 | engineered mutation |
Pro 373 | Ser 373 | engineered mutation |
Phe 375 | Ser 375 | engineered mutation |
Asn 417 | Lys 417 | engineered mutation |
Lys 440 | Asn 440 | engineered mutation |
Ser 446 | Gly 446 | engineered mutation |
Asn 477 | Ser 477 | engineered mutation |
Lys 478 | Thr 478 | engineered mutation |
Ala 484 | Glu 484 | engineered mutation |
Arg 493 | Gln 493 | engineered mutation |
Ser 496 | Gly 496 | engineered mutation |
Arg 498 | Gln 498 | engineered mutation |
Tyr 501 | Asn 501 | engineered mutation |
His 505 | Tyr 505 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
Polymers | Number of chains | 2 |
Total formula weight | 94454.5 | |
Branched | Number of molecules | 1 |
Total formula weight | 424.4 | |
Non-Polymers* | Number of molecules | 6 |
Total formula weight | 1171.4 | |
All* | Total formula weight | 96050.3 |